Nine new cytochalasan alkaloids from Chaetomium globosum TW1-1 (Ascomycota, Sordariales).

Chemical investigation on the methanol extract of Chaetomium globosum TW1-1, a fungus isolated from the common pillbug (Armadillidium vulgare), has resulted in the isolation of nine new highly oxygenated cytochalasan alkaloids, armochaetoglobins S-Z (1 and 3-9) and 7-O-acetylarmochaetoglobin S (2), together with eight structurally related known analogues (10-17). Their structures and absolute configurations were elucidated by spectroscopic analyses. Among them, compound 2 presents to be the first member of chaetoglobosin family with an acetyl group, and compounds 3 represents the first chaetoglobosin characterized by an 2',3'-epoxy-indole moiety. The discovery of these new compounds revealed the largely untapped chemical diversity of cytochalasans and enriched their chemical research. Compounds 1-9 were evaluated for their cytotoxic activities against five human cancer cell lines, and compounds 8 and 9 exhibited significant cytotoxic activities with IC50 values ranging from 10.45 to 30.42 μM.

Cytochalasans are an important class of natural products12, and they have attracted considerable attention from synthetic organic chemists345, biologists678, and phytochemists910111213 for decades because of their complex polycyclic skeletons and varied and often potent bioactivities, including antitumor614, anti-HIV15. and immunomodulatory activities7. Biogenetically, cytochalasans are biosynthesized by a large multi-domain enzymes of PKS-NRPS hybrid synthase and macrocyclization by means of a Diels-Alder reaction1617. To date, more than 200 cytochalasans have been isolated and identified from many genera of ascomycete fungi18192021.

The genus Chaetomium has been reported to be a rich source of cytochalasans, with about one fourth of the naturally occurring cytochalasans were reported from this genus alone10122223. As part of our ongoing research on structurally interesting and biologically significant cytochalasans from fungi24252627, a culture of Chaetomium globosum TW1-1 was chemically investigated. As a result, nine new highly oxygenated cytochalasan alkaloids, armochaetoglobins S–Z (1, 3, and 4–9) and 7-O-acetylarmochaetoglobin S (2) (Fig. 1), together with eight structurally related known analogues (10–17), were obtained from the methanol extract of solid rice culture of Chaetomium globosum TW1-1. In this paper, the fermentation, isolation, and structure elucidation of these compounds are described.

Figure 1

Structures of compounds 1–9.

Results and Discussion

Isolation and Structure Elucidation

The solid rice culture of Chaetomium globosum TW1-1 was extracted with methanol for five times at room temperature. The extract was subjected to series of chromatographic separation, including silica gel, RP-C18 (reversed-phase), Sephadex LH-20, and semi-preparative HPLC to yield nine new (1−9) and eight known cytochalasan alkaloids (10−17). The known compounds were identified as chaetoglobosins F (10)28, U (11)20, V (12)29, Y (13)22, cytoglobosin A (14)30, 20-dihydro-chaetoglobosin A (15)31, prochaetoglobosins I (16)31 and II (17)31 by comparing their NMR data with those reported in the literature.

The molecular formula of 1 was established as C32H40N2O6 by HRESIMS at m/z 549.2936 ([M + H]+, cacld for C32H41N2O6, 549.2965), indicating 13 degrees of unsaturation. The 13C NMR and DEPT spectra of compound 1 displayed 32 carbons, including four methyls, four methylenes, fifteen methines, and nine quaternary carbons. The carbon profile and characteristic 1H NMR signals (Table 1), as well as 2D NMR spectra of 1 revealed that it has a similar indole based cytochalasan skeleton as that of chaetoglobosin Q14. Comparison of the NMR data (Tables 1 and 2) of 1 with those of chaetoglobosin Q suggested their structural similarities. The main difference of the two compounds is the fragment from C-19 to C-22 in the macrocycle ring. The olefinic carbons C-21 and C-22 in chaetoglobosin Q were replaced by two methylene signals in the spectra of 1, which was suggested by 1H–1H COSY correlation of H-21/H-22 and HMBC cross-peaks from H-20 to C-19, C-21, and C-22. (Fig. 2) Additionally, chemical shifts of C-19 (δC 205.7) and C-20 (δC 72.4) combined with 1H–1H COSY cross-peak of H-20/H-21 and HMBC correlation from C-18-Me to C-19 indicated that the position of the carbonyl and the oxygenated methine were reversed comparing to chaetoglobosin Q.

Table 1

1H-NMR data of compounds 1–9 (400MHz, J in Hz).

Position	1a	2a	3b	4a	5a	6b	7a	8a	9a
3	3.81 dd (9.0, 4.6)	3.78 dd (8.9, 5.2)	4.13 dt (11.0, 5.4)	4.41 dd (8.9, 3.7)	3.83 dd (8.0, 6.4)	3.32 m	3.79 m	3.80 m	3.53 dd (9.8, 5.5)
4	2.50 m	2.75 m	2.52 m	2.10 m	2.63 br s	2.48 m	2.70 m	2.75 br d (6.4)	3.18 m
5	2.02 m	1.98 m	1.56 m	1.73 m		2.24 m	2.15 m	1.68 m
6					1.58 dd (8.9, 6.9)
7	3.16 d (11.7)	4.74 d (11.7)	2.89 d (4.9)	3.53 d (12.5)	3.07 dd (10.9, 8.9)	5.43 br s	3.31 overlapped	2.90 d (5.9)	4.03 br d (9.7)
8	2.63 dd (11.7, 10.3)	2.85 m	2.49 m	2.67 m	2.82 m	3.73 m	2.71 m	2.32 dd (10.5, 6.0)	2.29 dd (10.9, 9.7)
10	2.98 dd (14.6, 4.8)	2.91 dd (14.7, 5.7)	2.31 dd (12.4, 5.4)	3.13 dd (14.9, 3.4)	2.94 m	2.77 dd (14.4, 5.1)	2.87 dd (14.6, 5.2)	2.85 dd (14.4, 4.4)	2.88 dd (14.0, 5.5)
	2.80 dd (14.6, 4.7)	2.83 dd (14.7, 5.1)	1.44 dd (12.4, 11.0)	2.85 dd (14.9, 3.3)	2.84 m	2.68 dd (14.4, 4.9)	2.73 dd (14.6, 4.0)	2.59 dd (14.4, 7.7)	2.45 dd (14.0, 9.8)
11	1.02 d (6.6)	1.02 d (7.3)	1.07 d (7.3)	1.21 d (7.1)	1.01 s	0.96 d (7.2)	1.00 d (7.2)	0.79 d (7.3)	1.16 s
12	1.22 s	1.15 s	1.30 s	1.15 s	1.08 d (7.4)	3.89 br s	1.18 s	1.20 s	1.61 s
13	5.94 dd (14.5, 10.8)	5.98 dd (14.1, 10.2)	6.03 dd (14.6, 10.7)	5.58 dd (14.5, 10.6)	6.35 dd (15.0, 10.5)	6.25 dd (15.6, 10.5)	5.93 dd (15.3, 9.9)	6.37 dd (15.4, 1.5)	6.37 dd (14.3, 10.9)
14	2.12 ddd (14.5, 10.9, 2.5)	5.16 ddd (14.1, 11.0, 2.5)	5.25 ddd (14.6, 10.1, 2.6)	4.94 ddd (14.5, 11.0, 2.1)	5.20 ddd (15.0, 10.9, 2.4)	5.06 ddd (15.6, 10.9, 2.6)	5.11 ddd (15.3, 11.6, 3.8)	5.27 ddd (15.4, 11.4, 2.4)	5.33 ddd (14.3, 12.1. 2.3)
15	2.40 m	2.34 m	2.44 m	2.35 m	2.49 br d (14.8)	2.31 m	2.24 br d (12.5)	2.62 dd (14.0, 5.4)	2.68 m
	1.97 m	1.98 m	1.96 m	1.84 m	2.12 dt (14.8, 11.0)	1.92 m	1.85 dt (12.5, 11.7)	1.83 m	1.91 m
16	2.74 m	2.75 m	2.77 m	2.72 m	2.82 m	2.66 m	1.44 m	2.38 m	2.47 m
17	6.19 d (9.1)	6.21 d (8.7)	6.29 d (8.7)	5.98 d (10.2)	6.31 d (9.2)	6.15 d (9.2)	2.19 d (6.6)	2.87 br s	3.15 m
19								5.91 s	6.02 s
20	4.66 dd (6.2, 4.7)	4.71 t (5.5)	4.79 t (5.8)		4.80 dd (11.7, 5.4)	4.48 dd (11.2, 6.7)
21	1.60 m	1.68 m	1.57 m	2.24 m	1.83 m	1.47 m	2.02 m	2.53 dd (7.3, 5.6)	2.56 m
	1.36 m	1.46 m	1.42 m	1.62 m	1.70 m	1.27 m
22	2.50 m	2.64 m	2.63 m	2.49 m	3.05 m	2.52 m	2.70 m	3.09 dd (14.8, 5.6)	3.69 dd (16.3, 6.2)
	1.82 m	2.12 m	2.50 m	0.89 m	2.88 m	1.75 m	0.84 m	1.86 dd (14.8, 7.3)	2.65 dd (16.3, 4.9)
2′	7.03 br s	7.06 br s	4.99 d (3.5)	7.11 s	7.10 br s	7.09 d (1.9)	6.95 s	6.96 s	7.00 br s
4′	7.51 d (7.8)	7.52 d (7.8)	7.13 d (7.2)	7.58 d (7.7)	7.51 d (7.7)	7.49 d (7.8)	7.48 d (7.7)	7.48 d (7.8)	7.51 d (7.8)
5′	7.02 t (7.4)	7.02 t (7.4)	6.64 t (7.4)	7.06 t (7.9)	7.02 t (7.6)	6.96 t (7.0)	7.01 t (7.2)	7.01 dd (7.8, 7.2)	7.01 t (7.3)
6′	7.09 t (7.2)	7.09 t (7.2)	7.04 t (7.6)	7.12 t (7.3)	7.07 t (7.7)	7.03 t (7.1)	6.97 t (7.6)	7.06 dd (7.9, 7.2)	7.09 t (7.5)
7′	7.33 d (8.0)	7.33 d (8.1)	6.55 d (7.9)	7.35 d (8.0)	7.33 d (7.1)	7.30 d (8.0)	7.26 d (8.0)	7.28 d (7.9)	7.33 d (8.1)
16-Me	1.00 d (6.5)	1.01 d (6.7)	1.00 d (6.7)	0.98 d (6.6)	1.06 d (7.3)	0.97 d (6.6)	0.97 d (7.1)	0.67 d (6.8)	0.78 d (6.8)
18-Me	1.76 s	1.77 s	1.71 s	1.78 s	1.83 br s	1.68 s	2.66 s	2.09 s	2.16 s
C-2′′		1.98s

ain CD3OD.

bin DMSO–d6.

Table 2

13C NMR for compounds 1–9 (100 MHz, J in Hz).

No	1a	2a	3b	4a	5a	6b	7a	8a	9a
1	176.8	176.5	170.2	176.6	177.4	173.6	176.0	176.8	176.8
3	54.4	55.2	59.8	54.8	55.4	53.5	53.9	54.0	59.3
4	45.8	44.8	46.9	46.8	55.2	49.4	46.3	49.4	50.2
5	40.1	41.3	34.6	39.1	74.8	33.7	40.9	38.0	128.3
6	74.0	73.8	57.6	77.7	49.3	142.6	73.5	58.9	134.4
7	73.6	74.9	61.1	76.4	73.8	125.6	74.2	62.3	70.1
8	47.2	46.0	45.2	47.6	45.0	45.3	50.9	51.5	55.2
9	65.6	65.1	68.5	65.3	65.4	66.6	67.9	68.0	64.7
10	33.4	32.9	47.3	31.8	33.0	32.4	33.1	34.2	33.0
11	13.5	13.3	13.8	13.3	20.1	11.9	12.6	12.7	17.4
12	24.8	24.8	20.1	22.2	13.8	61.4	24.9	19.5	14.5
13	129.4	128.5	129.5	128.1	129.9	130.7	130.6	131.5	132.6
14	134.9	135.4	132.5	135.1	135.7	130.7	134.3	133.5	134.0
15	41.9	41.8	40.3	40.8	42.1	40.2	45.3	39.5	39.6
16	34.5	34.5	32.9	34.5	34.5	32.8	43.8	32.5	32.8
17	149.9	149.9	147.3	156.0	150.4	147.2	54.2	49.8	49.6
18	136.3	136.2	134.8	132.6	136.0	134.6	149.7	183.5	183.7
19	205.7	205.5	204.1	197.5	205.3	203.8	148.6	129.5	129.8
20	72.4	72.6	72.0	205.9	73.0	70.9	204.4	212.0	211.6
21	31.8	32.1	31.0	33.4	32.4	30.1	52.8	44.6	44.4
22	38.5	38.8	37.4	37.2	39.5	37.6	42.8	42.7	41.9
23	209.9	209.9	207.2	208.5	211.4	209.2	213.9	211.2	210.6
2′	125.6	125.3	82.4	126.5	124.5	124.5	125.8	125.1	124.7
3′	109.9	110.3	91.9	109.6	110.0	109.0	109.5	110.4	111.5
3′a	129.2	129.0	131.0	129.7	128.8	127.7	129.2	128.8	128.5
4′	119.3	119.2	122.6	119.6	119.2	118.3	119.4	119.3	119.2
5′	120.1	120.1	117.6	120.5	119.8	118.3	120.1	120.1	119.9
6′	122.5	122.5	129.0	122.7	122.4	120.7	122.3	122.5	122.4
7′	112.5	112.5	109.6	112.4	112.4	111.3	112.6	112.3	112.4
1′a	137.9	138.0	148.4	137.8	138.1	136.0	138.0	138.1	138.1
16-Me	20.1	20.1	19.8	19.8	20.1	19.7	21.7	16.3	15.9
18-Me	12.4	12.3	12.1	10.9	12.2	12.0	16.9	17.7	17.7
1′′		172.3
2′′		20.8

ain CD3OD.

bin DMSO–d6.

Figure 2

Key 2D NMR correlations for 1.

The relative configuration of compound 1 was established by a NOESY experiment (Fig. 2) aided by comparing the chemical shifts and coupling constants of 1 with the known analogues. The strong NOESY correlation of H-5 and H-8 implied a boat conformation of the six-membered ring and both protons were ambiguously assigned as β-orientations. Consequently, NOESY correlations of Me-11 to H-3 and Me-12, and of Me-12 to H-7 revealed their co-facial and α-orientation. In addition, NOESY interaction of H-4 and H-10 suggested their β-orientations. The geometries of the double bonds (Δ13 and Δ17) in the 13-membered ring were determined to be trans (E) by the large coupling constant (J = 14.6 Hz) and NOESY correlation of H-16/18-Me, respectively. Furthermore, the α-orientation of 16-Me and β-orientation of 20-OH were determined by NOESY correlations from H-14 to H-8 and H-16, from H-17 to H-20 and H-15α, and from H-13 to H-15α and H-7. The absolute configuration of 1 was established by comparing the ECD spectrum (Fig. 3) of 1 with that of armochaetoglobin F26, whose absolute configuration was undoubtedly identified by X-Ray diffraction analysis. The final name of armochaetoglobin S was assigned to 1.

Figure 3

ECD curves for compounds 1−6.

The molecular weight of compound 2 was 42 mass units more than that of 1 as revealed by HRESIMS ion peak at m/z 613.2859 ([M + Na]+, cacld for C34H42N2O7Na, 613.2890). Comparison of the NMR data (Tables 1 and 2) for 2 and 1 revealed a high level of similarity with the only significant difference of the presence of an additional acetyl (δC 20.8 and 172.3; δH 1.98, 3H, s). The acetyl group was located at C-7 based on HMBC correlations from H-7 to C-1′′. Further analyses of 2D NMR data (1H–1H COSY, HMBC, and NOESY) of 2 confirmed the structure and relative configuration of 2, and it was given the trivial name 7-O-acetylarmochaetoglobin S. To the best of our knowledge, compound 2 presents to be the first acetylated chaetoglobosin.

Compound 3 was obtained as colorless amorphous powder. The HRESIMS data showed a quasi-molecular ion peak at m/z 569.2628 ([M + Na]+), corresponding to a molecular formula of C32H38N2O6 with 15 degrees of unsaturation. Comparison of the NMR data (Tables 1 and 2) of 3 with those of chaetoglobosin F(10)28 suggested their structural similarities, however, with higher degrees of oxidation than that of 10. The unexpected epoxy ring fused to the indole ring in compound 3 was evidenced by the chemical shifts of C-2′ (δC 82.4) and C-3′ (δC 91.9) and HMBC correlations from H-2′ to C-10, C-3′, C-1′a, and C-3′a. The overall NMR data, including HSQC, 1H–1H COSY, and HMBC spectra, allowed the elucidation of the planar structure of 3. Compound 3 represents the first example of naturally occurring chaetoglobosin characterized by 2′,3′-epoxy-indole moiety. The configuration for the core skeleton of 3 was assigned to be as the same as that of 10 by a NOESY experiment and further confirmed by comparison of their NMR data. Based on the identical ECD curves (Fig. 3) of 3 and 1, the stereochemistry of 3 was elucidated.

The molecular formula of compound 4 was determined as C32H38N2O6 according to its HRESIMS data (m/z 569.2609, [M + Na]+, cacld for C32H38N2O6Na, 569.2628). Exhaustive interpretation of the 1H and 13C NMR data (Tables 1 and 2) revealed that 4 was also a chaetoglobosin derivative. Moreover, its NMR data closely resembled those of 1 according to the consequent comparison, in which the major difference of the chemical shifts were noticed in the position of C-20 in the macrocyclic ring. A detailed comparison of the 13C NMR spectra of 4 and 1 suggested that the oxygenated methine (C-20, δC 72.6) in 1 was replaced by a carbonyl group (δC 205.9) in 4. Furthermore, the carbon signal of the methine (C-6) at δC 74.0 in 1 shifted downfield to δC 77.7 in 4, which could only be rationalized by supposing the change of configuration of C-6. This hypothesis was evidenced by NOESY correlation of Me-12/H-8 and the absence of the NOESY cross-peak between Me-12 and Me-11. Additional supporting evidences for the structure of 4 were provided by 1H–1H COSY, HMBC, NOESY, and ECD spectra, which allowed the confirmation of the planar structure and configuration of 4.

Armochaetoglobin V (5) had the same molecular formula as that of 1, suggesting that 5 is an isomer of 1. Comparison of its NMR spectra (Tables 1 and 2) with that of 1 disclosed that the 6,7-diol in 1 was substituent by a 5,7-diol in 5, which was evidenced by chemical shifts of C-5 and C-6 (δC 40.1 and 74.0 for 1; δC 74.8 and 49.3 for 5), and further confirmed by 1H–1H COSY cross-peak of H-6/H-7 and HMBC correlations from Me-12 to C-5, C-6, and C-7. The configurations of the two hydroxyls were assigned to be co-facial and β-oriented as revealed by NOESY correlations of Me-3 to Me-11 and Me-12, and of Me-12 to H-7. As the first member of chaetoglobosin with a hydroxyl at C-5, compound 5 was outstanding from the chaetoglobosin family.

Compound 6 was obtained as white amorphous powder, which possessed a molecular formula of C32H38N2O5, with 15 degrees of unsaturation, based on the [M + Na]+ peak at m/z 553.2660 (calcd for 553.26784) in the positive HRESIMS. The 1H and 13C NMR data of 6 (Tables 1 and 2) resembled those of 1, which indicated that they share the same chaetoglobosin skeleton. However, the downfield shifted chemical shifts of H-7 (δH 5.43) and H-12 (δH 3.89) in compound 6, suggested the vicinal diol at C-6 and C-7 in 1 were replaced by a Δ6 double bond in 6. Moreover, the methyl (C-12) in 1 was oxygenated to be a hydroxymethyl (δC 61.4). These speculations were further supported by combination of HRESIMS and 2D NMR data (1H–1H COSY, HSQC, and HMBC). Further analyses of its NOESY spectrum and ECD curve established the absolute configuration of 6 and the trivial name armochaetoglobin W was given.

HRESIMS analysis of 7 indicated that it possessed the molecular formula of C32H38N2O6. The 1H and 13C NMR data for 7 (Tables 1 and 2) were similar to those of chaetoglobosin U (11)20. The major differences of them were the chemical shifts of C-6 and C-7 (δC 73.5 and 74.2 in 7; δC 57.5 and 60.9 in 11). The above analyses, combined with the HRESIMS, suggested that the epoxy ring of 11 was hydrolyzed to be a vicinal diol at C-6 and C-7 in compound 7. The observed HMBC correlations from H-4 to C-6, from H-11 to C-4, C-5, and from C-6, and H-12 to C-5, C-6, and C-7 supported the above deduction. In addition, the similar NOESY spectra and identical ECD curves of the two compounds allowed the assignment of the absolute configuration of 7. Therefore, the structure of compound 7 was established as shown and named armochaetoglobin X.

The HRESIMS data of 8 exhibited an ion peak at m/z 535.2509 (calcd for C32H36N2O4Na, 535.2573), suggesting a molecular formula of C32H36N2O4, with 16 degrees of unsaturation. Its NMR spectra (Tables 1 and 2) were in general similar to those of 11, especially in rings A–C. However, inspection of the 1H NMR spectrum of 8 revealed a new olefinic proton at δH 5.91 that was not observed for 11. In addition, the associated carbon signal of C-18 was downfield shifted from 147.2 to 183.5 ppm. Examination of the 2D NMR data of 8 confirmed that an additional olefinic proton was assigned to C-18 of the trisubstituted double bond in 8, which replaced the hydroxyl at the tetrasubstituted double bond in 11. The relative configuration of 8 was established by a NOESY experiment, in which the correlation pattern of the rings A and B were similar to other chaetoglobosin. However, the observed NOESY correlations of H-21 to 16-Me and H-13 suggested that their co-facial and α-oriented. In addition, the β conformation of H-17 was determined by NOESY correlation of H-17 and H-16, and aided by the lack of NOESY cross-peak between H-17 and 16-Me.

The absolute configuration of 8 was assigned comparison of its ECD spectrum (Fig. 4) with that of armochaeglobine C25, whose absolute configuration was determined by X-ray diffraction analysis and reported by us previously.

Figure 4

ECD curves of armochaeglobine C and compounds 8 and 9.

Armochaetoglobin Z (9) was obtained as a colorless amorphous powder. Its molecular formula was determined as C32H36N2O4 by HRESIMS. Detailed comparison of the NMR data of 9 with that of 8 suggested a similar structure for them. The main differences of the two compounds were that the epoxy group in 8 was substituted by a double bond at C-5 and a hydroxyl at C-7 in 9, which was evidenced by analyses of their NMR data and HMBC correlations from Me-11 to C-4, C-5, and C-6, from Me-12 to C-5, C-6, C-7, and from H-7 to H-8 and H-13. The 7-OH was revealed to β-oriented according to NOESY correlations of H-7 to Me-11 and Me-12. In addition, the ECD curve of 9 (Fig. 4) was nearly identical to that of armochaeglobine C and 8, leading to the final assignment of its absolute configuration.

Evaluation of cytotoxicity in human cell lines

Cytochalasans are commonly reported to exhibit cytotoxic effects and some of them have been considered as starting molecular for anti-tumor drug candidates. Therefore, in this case, compounds 1–9 were all evaluated for their cytotoxic activities against five human tumor cell lines (HL-60, A-549, SMMC-7721, MCF-7, and SW-480) and the immortalized non-cancerous Beas-2B human bronchial epithelial cell line, in vitro, by the MTS method (Table S1, SI). According to the reported structure-activity relationships, the epoxide at C-6/C-7 and the aromatic substituent at C-10 were required for cytotoxicity1, and our results were consistent with literature. Compound 8 exhibited most potent cytotoxic activities toward HL-60, A-549, SMMC-7721, and SW-480 cell lines, and in contrast, compound 9, with the epoxide hydrolysed, only exhibited cytotoxicity against HL-60 and A-549 cell lines. Moreover, compound 3 was inactive at a concentration of 40 μM, which might be due to the destruction of the aromatic feature of the substituent at C-10 induced by epoxidation at the indole ring.

In summary, the fungus Chaetomium globosum has provided a rich spectrum of indole-based cytochalasans. In this study, nine new highly oxygenated cytochalasan derivatives (1–9), along with eight known chaetoglobosins, were isolated from the rice culture of Chaetomium globosum, isolated from the common pillbug (Armadillidium vulgare). The structures of the new compounds were determined by a combination of spectroscopic and ECD computational methods. A literature search revealed that changes among chaetoglobosins commonly occur in the positions of C-5–C-7, C-12, and C-19–C-22, with the other positions relatively fixed. Compound 2 is the first member of the chaetoglobosin family with an acetyl group. Compound 3 and 5 present to be the first examples of natural chaetoglobosins characterized by oxygenation of indole moiety and hydroxylation of C-5, respectively. In addition, compounds 8 and 9 exhibited significant cytotoxic activities with IC50 values ranging from 10.45 to 30.42 μM.

Methods

General experimental procedures

Optical rotations were determined with a Perkin-Elmer 341 polarimeter. UV, CD, and FT-IR spectra were measured using a Varian Cary 50, a JASCO-810 CD spectrometer, and a Bruker Vertex 70 instruments, respectively. NMR spectra were recorded on a Bruker AM-400 spectrometer, and the 1H and 13C NMR chemical shifts were referenced to the solvent or solvent impurity peaks for CD3OD (δH 3.31 and δC 49.0) and DMSO-d6 (δH 2.50 and δC 39.5). High-resolution electrospray ionization mass spectra (HRESIMS) were carried out in the positive ion mode on a Thermo Fisher LC-LTQ-Orbitrap XL spectrometer. Semipreparative HPLC was carried out on an Agilent 1200 quaternary system with a UV detector or a Dionex HPLC system equipped with an Ultimate 3000 pump, an Ultimate 3000 autosamper injector, and an Ultimate 3000 DAD detector controlled by Chromeleon software (version 6.80), using a reversed-phased C18 column (5 μm, 10 × 250 mm). Column chromatography was performed using silica gel (100–200 and 200–300 mesh), ODS (50 μm), and Sephadex LH-20. Thin-layer chromatography (TLC) was performed with silica gel 60 F254 and RP-C18 F254 plates.

Fungal material

The strain Chaetomium globosum TW1-1 was isolated from Armadillidium vulgare in November 2012 at Tongji Medical College, Hubei Province, China. The 16S RNA sequence data for this strain have been submitted to the DDBJ/EMBL/GenBank under accession No. KF993614. A voucher sample, CCM20121113, was deposited in the culture collection of Tongji Medical College, Huazhong University of Science and Technology.

Fermentation, extraction, and isolation

The strain was cultured on potato dextrose agar (PDA) at 28 °C for 7 days in stationary phase to prepare the seed culture. Then the Agar plugs were cut into small pieces and inoculated into 250 Erlenmeyer flasks (1 L), previously sterilized by autoclaving, each containing 200 g rice and 200 mL distilled water. All flasks were incubated at 28 °C for 28 days. Following incubation, the growth of cells was stopped by adding 300 mL EtOAc to each flask, and the culture was homogenized. Then the suspension was extracted by ultrasonic extraction with methanol for five times at room temperature. The methanol was removed under reduced pressure to yield a brown extract (827 g), and then suspended in H2O (5L), and partitioned with EtOAc against water. The EtOAc soluble extract (230 g) was separated by chromatography on a silica gel column (80–120 mesh, 10 × 120 cm, CC) eluting with CH2Cl2/MeOH (50:1–0:1) to yield six fractions (Fr. 1–Fr. 8). Fr.3 was further purified by MPLC ODS (40%–100% MeOH in H2O) to obtain four subfractions (Fr. 4.1−Fr. 4.4). Fr.4.2 was purified over Sephadex LH-20 (MeOH) followed by MPLC ODS (40% MeOH in H2O) and finally by repeated semi-preparative HPLC to yield 8 (11.6 mg), 10 (6.7 mg), 11 (20.4 mg), 13 (17.6 mg), and 14 (6.3 mg). Fr.4.3 was separated over repeated silica gel CC (petroleum ether to acetone, 5:1 → 2:1), Sephadex LH-20 (MeOH), and semi-preparative HPLC to yield 9 (7.2 mg), 12 (3.6 mg), 15 (6.4 mg), 16 (12.9 mg), and 17 (4.5 mg). Fr. 4 was applied to MPLC ODS (40%–100% MeOH in H2O) and then to Sephadex LH-20 (MeOH) and repeated silica gel CC (petroleum ether to acetone, 4:1 → 2:1) to obtain two mixtures (I and II). Mixture I was purified by repeated semi-preparative HPLC (50% MeOH in H2O and 40% MeCN in H2O) to obtain 1 (3.0 mg) and 2 (27.3 mg), and mixture II was purified by semi-preparative HPLC (55% MeOH in H2O) to obtain 3 (4.8 mg). Fr. 6 was applied to MPLC ODS (20%–80% MeOH in H2O) to obtain six subfractions (Fr. 6.1−Fr. 6.6). Fr. 6.2 was separated with Sephadex LH-20 (MeOH) and silica gel CC (petroleum ether to acetone, 2:1) to obtain two mixtures (Fr. 6.2.1–Fr. 6.2.2). Fr. 6.2.1 was purified by semi-preparative HPLC (45% MeOH in H2O) to obtain 4 (4.5 mg) and 6 (2.0 mg), while Fr 6.2.2 was purified by semi-preparative HPLC (36% MeCN in H2O) to yield 5 (2.1 mg) and 7 (2.0 mg).

Armochaetoglobin S (1): colorless powder; –13.5 (c = 0.53, MeOH); UV (MeOH) λmax (log ε) = 203 (4.36) and 222 (4.45) nm; IR vmax = 3379, 2966, 2929, 1682, 1554, 1431, and 1268 cm–1; CD (MeOH) λmax (Δε) 224 (−7.9), 272 (+0.6) nm; For 1H NMR (400 MHz) and 13C NMR (100 MHz) data, see Tables 1 and 2; HRESIMS [M + H]+ m/z 549.2936 (calcd for C32H42N2O6, 549.2965).

7-O-acetylarmochaetoglobin S (2): colorless powder; + 12.7 (c = 0.34, MeOH); UV (MeOH) λmax (log ε) = 203 (4.42) and 221 (4.47) nm; IR (KBr) vmax = 3389, 2968, 2930, 1686, 1551, 1454, and 1239 cm–1; CD (MeOH) λmax (Δε) 223 (−10.3), 271 (0.6) nm; For 1H NMR (400 MHz) and 13C NMR (100 MHz) data, see Tables 1 and 2; HRESIMS [M + Na]+ m/z 613.2859 (calcd for C34H42N2O7Na, 613.2890).

Armochaetoglobin T (3): colorless powder; + 21.0 (c = 0.23, MeOH); UV (MeOH) λmax (log ε) = 204 (4.55) and 222 (4.59) nm; IR vmax = 3388, 2973, 1670, 1616, 1562, 1409, 1333, and 1192 cm–1; CD (MeOH) λmax (Δε) 227 (−6.4) nm; For 1H NMR (400 MHz) and 13C NMR (100 MHz) data, see Tables 1 and 2; HRESIMS [M + Na]+ m/z 569.2628 (calcd for C32H38N2O6Na, 569.2606).

Armochaetoglobin U (4): colorless powder; –61.0 (c = 0.20, MeOH); UV (MeOH) λmax (log ε) = 221 (4.48) nm; IR (KBr) vmax = 3378, 2969, 2927, 1703, 1454, 1430, 1361, and 1228 cm–1; CD (MeOH) λmax (Δε) 223 (−8.6), 291 (−5.6) nm; For 1H NMR (400 MHz) and 13C NMR (100 MHz) data, see Tables 1 and 2; HRESIMS [M + Na]+ m/z 569.2609 (calcd for C32H38N2O6Na, 569.2628).

Armochaetoglobin V (5): colorless powder; –35.6 (c = 0.06, MeOH); UV (MeOH) λmax (log ε) = 222 (4.56) and 269 (3.68), nm; IR (KBr) vmax = 3413, 2966, 2928, 1685, 1453, 1435, and 1234 cm–1; CD (MeOH) λmax (Δε) 222 (−6.3) nm; For 1H NMR (400 MHz) and 13C NMR (100 MHz) data, see Tables 1 and 2; HRESIMS [M + Na]+ m/z 571.2767 (calcd for C32H40N2O6Na, 571.2784).

Armochaetoglobin W (6): colorless powder;  + 6.4 (c = 0.34, MeOH); UV (MeOH) λmax (log ε) = 203 (4.55), 222 (4.62), and 283 (3.79) nm; IR (KBr) vmax = 3379, 2964, 2926, 1700, 1454, 1431, 1382, and 1048 cm–1; CD (MeOH) λmax (Δε) 227(−9.8) nm; For 1H NMR (400 MHz) and 13C NMR (100 MHz) data, see Tables 1 and 2; HRESIMS [M + Na]+ m/z 553.2660 (calcd for C32H38N2O5Na, 553.2678).

Armochaetoglobin X (7): colorless powder; –70.6 (c = 0.07, MeOH); UV (MeOH) λmax (log ε) = 221 (4.43) and 269 (3.93), nm; IR (KBr) vmax = 3318, 2967, 2927, 1700, 1428, 1360, 1228, and 1108 cm–1; CD (MeOH) λmax (Δε) 221 (−10.5), 257 (−9.6) nm; For 1H NMR (400 MHz) and 13C NMR (100 MHz) data, see Tables 1 and 2; HRESIMS [M + H]+ m/z 547.2789 (calcd for C32H39N2O6, 547.2808).

Armochaetoglobin Y (8): colorless powder;  + 75.2 (c = 0.46, MeOH); UV (MeOH) λmax (log ε) = 203 (4.50), 222 (4.62), 283 (3.80) nm; IR (KBr) vmax = 3401, 2966, 2924, 1688, 1616, 1454, 1432, 1382, and 1106 cm–1; CD (MeOH) λmax (Δε) 206 (+0.1), 222 (−0.6), 243 (+2.6) nm; For 1H NMR (400 MHz) and 13C NMR (100 MHz) data, see Tables 1 and 2; HRESIMS [M + Na]+ m/z 535.2509 (calcd for C32H36N2O4Na, 535.2573).

Armochaetoglobin Z (9): colorless powder;  + 73.6 (c = 0.39, MeOH); UV (MeOH) λmax (log ε) = 203 (4.32) and 222 (4.26) nm; IR (KBr) vmax = 3380, 2952, 2914, 1685, 1614, 1434, 1379, 1227, and 1106 cm–1; CD (MeOH) λmax (Δε) 215 (+7.5), 239 + 4.5) nm; For 1H NMR (400 MHz) and 13C NMR (100 MHz) data, see Tables 1 and 2; HRESIMS [M + H]+ m/z 513.2734 (calcd for C32H37N2O4, 513.2753).

Cytotoxic assay

Five human cancer cell lines including HL-60, SMMC-7721, A-549, MCF-7, and SW-480, as well as the noncancerous cell line, the Beas-2B human bronchial epithelial cell line, were used in the cytotoxic activity assay. Cytotoxic activity was measured as described in our previous report32.

Additional Information

How to cite this article: Chen, C. et al. Nine new cytochalasan alkaloids from Chaetomium globosum TW1-1 (Ascomycota, Sordariales). Sci. Rep. 6, 18711; doi: 10.1038/srep18711 (2016).